ANTI-CGRP ANTIBODY DOSING AND SCREENING METHODS
Abstract:
The present invention relates the use of monoclonal anti-calcitonin gene-related peptide (CGRP) antagonist antibodies or anti-CGRP receptor antibodies in subjects that do not respond adequately to a first dose but respond to the second dose.
Information query
Patent Agency Ranking
0/0